Compare AstraZeneca plc (AZN) vs First Trust NASDAQ Clean Edge Green Energy Idx Fd (QCLN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AstraZeneca plc vs First Trust NASDAQ Clean Edge Green Energy Idx Fd — how do they compare? AstraZeneca plc trades at $157.15 (market cap $248.14B), while First Trust NASDAQ Clean Edge Green Energy Idx Fd trades at $53.1. The key difference: AstraZeneca plc pays a 2.01% dividend while First Trust NASDAQ Clean Edge Green Energy Idx Fd pays none, and First Trust NASDAQ Clean Edge Green Energy Idx Fd is trading nearer its 52-week high, AstraZeneca plc nearer its low. Which is the better fit depends on your goals.
| AZN | QCLN | |
|---|---|---|
Market Cap | $248.14B | — |
Sector | Health | Sector/Thematic |
52-Week High | $209.48 | $68.47 |
52-Week Low | $147.06 | $36.27 |
Enterprise Value | $275.41B | — |
Dividend Yield | 2.01% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AstraZeneca (AZN) trades at $158.48, down 2.12% amid bearish technical signals and merger speculation. The stock shows strong fundamentals with revenue growth from $54.1B in 2024 to $58.7B in 2025 and net income reaching $10.2B. Recent earnings beats and a 47.5% analyst buy rating contrast with technical indicators showing oversold conditions near key support at $155.
Investment outlook remains positive based on earnings momentum and valuation metrics (P/E 23.76), though risks include potential merger integration challenges and ongoing legal investigations. The company's robust cash flow generation and dividend payments provide shareholder value support despite near-term volatility.
QCLN trades at $53.09, up 2.0% with a bullish technical signal from moving averages. The ETF benefits from clean energy sector momentum driven by data center power demand and global energy security concerns. Recent news highlights clean energy ETF gains amid volatile oil markets, though regulatory challenges and supply chain pressures present headwinds. Key support sits at $51-52 with resistance at $53-55.
The outlook remains positive given structural energy transition trends, but investors face regulatory uncertainty from U.S. permit delays and China trade tensions. Wall Street sentiment leans bullish on clean energy themes, though valuation metrics are unavailable for this ETF. Risks include geopolitical supply chain disruptions and policy shifts affecting renewable project economics.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AstraZeneca plc
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.
Read more on AZN →About First Trust NASDAQ Clean Edge Green Energy Idx Fd
QCLN invests in U.S.-listed companies engaged in clean energy technologies. It focuses on solar power, wind, electric vehicles, and energy storage, with major holdings in firms like Tesla, ON Semiconductor, and Rivian.
Read more on QCLN →
